PBPK Modeling Approach to Predict the Behavior of Drugs Cleared by Metabolism in Pregnant Subjects and Fetuses
This study aimed to develop a physiologically based pharmacokinetic (PBPK) model that simulates metabolically cleared compounds’ pharmacokinetics (PK) in pregnant subjects and fetuses. This model accounts for the differences in tissue sizes, blood flow rates, enzyme expression levels, plasma protein...
Hlavní autoři: | Maxime Le Merdy, Ke Xu Szeto, Jeremy Perrier, Michael B. Bolger, Viera Lukacova |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
MDPI AG
2024-01-01
|
Edice: | Pharmaceutics |
Témata: | |
On-line přístup: | https://www.mdpi.com/1999-4923/16/1/96 |
Podobné jednotky
-
Clinical Ocular Exposure Extrapolation for a Complex Ophthalmic Suspension Using Physiologically Based Pharmacokinetic Modeling and Simulation
Autor: Maxime Le Merdy, a další
Vydáno: (2024-07-01) -
Permeability of Gemcitabine and PBPK Modeling to Assess Oral Administration
Autor: Abigail Ferreira, a další
Vydáno: (2021-12-01) -
Development, testing, parameterisation, and calibration of a human PBPK model for the plasticiser, di-(2-ethylhexyl) terephthalate (DEHTP) using in silico, in vitro and human biomonitoring data
Autor: Kevin McNally, a další
Vydáno: (2023-02-01) -
Development, Testing, Parameterisation and Calibration of a Human PBPK Model for the Plasticiser, Di-(2-propylheptyl) Phthalate (DPHP) Using in Silico, in vitro and Human Biomonitoring Data
Autor: Kevin McNally, a další
Vydáno: (2021-09-01) -
Refinement and calibration of a human PBPK model for the plasticiser, Di-(2-propylheptyl) phthalate (DPHP) using in silico, in vitro and human biomonitoring data
Autor: Kevin McNally, a další
Vydáno: (2023-02-01)